Co-Authors
This is a "connection" page, showing publications co-authored by Nishant Agrawal and Rifat Hasina.
Connection Strength
1.057
-
Early Dynamics of Circulating Tumor HPV-DNA with Neoadjuvant Chemotherapy and Response-Adapted De-escalation in Human Papillomavirus-Associated Oropharyngeal Cancer. Clin Cancer Res. 2025 Aug 01; 31(15):3150-3159.
Score: 0.238
-
Microbial Changes Associated With Oral Cavity Cancer Progression. Otolaryngol Head Neck Surg. 2023 06; 168(6):1443-1452.
Score: 0.200
-
Genomics of mucoepidermoid and adenoid cystic carcinomas. Laryngoscope Investig Otolaryngol. 2018 02; 3(1):56-61.
Score: 0.142
-
Role of dental hardware in oral cavity squamous cell carcinoma in the low-risk nonsmoker nondrinker population. Head Neck. 2018 04; 40(4):784-792.
Score: 0.142
-
Tumor DNA: an emerging biomarker in head and neck cancer. Cancer Metastasis Rev. 2017 09; 36(3):515-523.
Score: 0.138
-
Neoadjuvant Nivolumab Plus Chemotherapy Followed By Response-Adaptive Therapy for HPV+ Oropharyngeal Cancer: OPTIMA II Phase 2 Open-Label Nonrandomized Controlled Trial. JAMA Oncol. 2024 Jul 01; 10(7):923-931.
Score: 0.055
-
Author Correction: A nanoengineered topical transmucosal cisplatin delivery system induces anti-tumor response in animal models and patients with oral cancer. Nat Commun. 2022 Dec 21; 13(1):7865.
Score: 0.050
-
A nanoengineered topical transmucosal cisplatin delivery system induces anti-tumor response in animal models and patients with oral cancer. Nat Commun. 2022 08 17; 13(1):4829.
Score: 0.049
-
Ultrasensitive detection of tumor-specific mutations in saliva of patients with oral cavity squamous cell carcinoma. Cancer. 2021 05 15; 127(10):1576-1589.
Score: 0.043